Quick Answer
PMV Pharmaceuticals, Inc. reported Stockholders Equity of $104.71 million for fiscal year 2025.
PMV Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $104.71M | -40.5% |
| 2024 | $176.08M | -22.0% |
| 2023 | $225.69M | -8.3% |
| 2022 | $246.03M | -20.3% |
| 2021 | $308.56M | -14.1% |
| 2020 | $359.12M | +609.6% |
| 2019 | -$70.47M | -52.7% |
| 2018 | -$46.14M | -55.2% |
| 2017 | -$29.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $121.00M | -38.9% | -13.9% |
| June 30, 2025 | $140.60M | -34.4% | -12.2% |
| March 31, 2025 | $160.11M | -24.7% | -9.1% |
| December 31, 2024 | $176.08M | -22.0% | -11.0% |
| September 30, 2024 | $197.91M | -16.7% | -7.7% |
| June 30, 2024 | $214.32M | -1.6% | +0.8% |
| March 31, 2024 | $212.68M | -7.6% | -5.8% |
| December 31, 2023 | $225.69M | -8.3% | -5.0% |
- PMV Pharmaceuticals, Inc. showed a decrease of -40.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, PMV Pharmaceuticals, Inc.’s stockholders equity has grown by 452.2% (from -$29.73 million to $104.71 million).
- The most recent figure is from PMV Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: